Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Collinson

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|October 12, 2017
Trial of Tocilizumab in Giant-Cell ArteritisJohn H Stone, Micki Klearman, Neil Collinson
CNS Spectrums|December 25, 2004
Development of subtype selective GABAA modulatorsGerard R Dawson, Neil Collinson, John R Atack
Arthritis Care & Research|August 19, 2014
Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbiditiesHans Petri, Alan Nevitt, Khaled Sarsour, et al.
International Journal of Rheumatology|April 17, 2015
Development and implementation of a double-blind corticosteroid-tapering regimen for a clinical trialNeil Collinson, Katie Tuckwell, Frank Habeck, et al.
Arthritis Research & Therapy|February 22, 2019
Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trialVibeke Strand, Sophie Dimonaco, Katie Tuckwell, et al.
Seminars in Arthritis and Rheumatism|July 6, 2016
Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysisMichael S Broder, Khaled Sarsour, Eunice Chang, et al.
Rheumatology (Oxford, England)|May 14, 2010
Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)Andrea Rubbert-Roth, Paul P Tak, Cristiano Zerbini, et al.
The Pediatric Infectious Disease Journal|June 10, 2020
Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children: A Randomized, Double-blind, Active Controlled Phase 3 Safety and Efficacy Trial (miniSTONE-2)Jeffrey Baker, Stanley L Block, Balpreet Matharu, et al.
Rheumatology and Therapy|February 2, 2019
Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims DataSara Gale, Huong Trinh, Katie Tuckwell, et al.
Microbiology Spectrum|June 20, 2023
A Phase 2 Randomized Trial Evaluating the Antiviral Activity and Safety of the Direct-Acting Antiviral Bemnifosbuvir in Ambulatory Patients with Mild or Moderate COVID-19 (MOONSONG Study)Marta Boffito, Eamon Dolan, Karishma Singh, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|October 12, 2017
Trial of Tocilizumab in Giant-Cell ArteritisJohn H Stone, Micki Klearman, Neil Collinson
CNS Spectrums|December 25, 2004
Development of subtype selective GABAA modulatorsGerard R Dawson, Neil Collinson, John R Atack
Arthritis Care & Research|August 19, 2014
Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbiditiesHans Petri, Alan Nevitt, Khaled Sarsour, et al.
International Journal of Rheumatology|April 17, 2015
Development and implementation of a double-blind corticosteroid-tapering regimen for a clinical trialNeil Collinson, Katie Tuckwell, Frank Habeck, et al.
Arthritis Research & Therapy|February 22, 2019
Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trialVibeke Strand, Sophie Dimonaco, Katie Tuckwell, et al.
Seminars in Arthritis and Rheumatism|July 6, 2016
Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysisMichael S Broder, Khaled Sarsour, Eunice Chang, et al.
Rheumatology (Oxford, England)|May 14, 2010
Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)Andrea Rubbert-Roth, Paul P Tak, Cristiano Zerbini, et al.
The Pediatric Infectious Disease Journal|June 10, 2020
Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children: A Randomized, Double-blind, Active Controlled Phase 3 Safety and Efficacy Trial (miniSTONE-2)Jeffrey Baker, Stanley L Block, Balpreet Matharu, et al.
Rheumatology and Therapy|February 2, 2019
Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims DataSara Gale, Huong Trinh, Katie Tuckwell, et al.
Microbiology Spectrum|June 20, 2023
A Phase 2 Randomized Trial Evaluating the Antiviral Activity and Safety of the Direct-Acting Antiviral Bemnifosbuvir in Ambulatory Patients with Mild or Moderate COVID-19 (MOONSONG Study)Marta Boffito, Eamon Dolan, Karishma Singh, et al.
Pageof 3